Notably, it seemed that CRC patients with low C5aR1 expression in TAMs exhibited longer overall survival when compared to CRC patients with high C5aR1 expression in TAMs (Supplementary Fig. 5C). This evidence concerns the gene C5AR1 and colorectal carcinoma.